Literature DB >> 11232200

Mechanisms of ascites formation.

A Cárdenas1, R Bataller, V Arroyo.   

Abstract

Ascites is the most common complication of cirrhosis. It is associated with profound changes in the splanchnic and systemic circulation and with renal abnormalities. The development of ascites is related to the existence of severe sinusoidal portal hypertension that causes marked splanchnic arterial vasodilation and a forward increase in the splanchnic production of lymph. Splanchnic arterial vasodilation also produces arterial vascular underfilling, arterial hypotension, compensatory activation of the RAAS, SNS, and AVP, and a continuous sodium and water retention, leading to ascites formation. Now, therefore, the splanchnic arterial circulation, rather than the venous portal system, is believed to be involved in the pathogenesis of ascites formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11232200     DOI: 10.1016/s1089-3261(05)70118-5

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  11 in total

1.  Tetrandrine ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.

Authors:  Hai Wang; Xiaoping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

2.  Ascites.

Authors:  Nelson Garcia; Arun J. Sanyal
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

Review 3.  Pathophysiology of portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Clin Liver Dis       Date:  2014-02-25       Impact factor: 6.126

4.  Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin.

Authors:  Matteo Bonatti; Riccardo Valletta; Giulia A Zamboni; Fabio Lombardo; Maria Senoner; Mariachiara Simioni; Guenther Schifferle; Giampietro Bonatti
Journal:  Eur Radiol       Date:  2019-01-14       Impact factor: 5.315

5.  Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats.

Authors:  Flávia Regina Carreño; Lisa L Ji; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-17       Impact factor: 3.619

6.  Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites.

Authors:  Mohammed Abdelhamid El-Bokl; Bahaa Eldeen Senousy; Khaled Zakaria El-Karmouty; Inas El Khedr Mohammed; Sherif Monier Mohammed; Sherif Sadek Shabana; Hassan Shalaby
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

Review 7.  Evaluation and management of patients with refractory ascites.

Authors:  Bahaa Eldeen Senousy; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

8.  Treatment of Ascites.

Authors:  Jayanta Choudhury; Arun J. Sanyal
Journal:  Curr Treat Options Gastroenterol       Date:  2003-12

Review 9.  The lymphatic vascular system in liver diseases: its role in ascites formation.

Authors:  Chuhan Chung; Yasuko Iwakiri
Journal:  Clin Mol Hepatol       Date:  2013-06-27

10.  Quantitative modeling of the physiology of ascites in portal hypertension.

Authors:  David G Levitt; Michael D Levitt
Journal:  BMC Gastroenterol       Date:  2012-03-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.